Skip to main navigation Skip to search Skip to main content

Pulmonary hypertension secondary to neurofibromatosis: Intimal fibrosis versus thromboembolism

  • Noah Samuels
  • , Neville Berkman
  • , Eli Milgalter
  • , Jacob Bar-Ziv
  • , Gail Amir
  • , Mordechai R. Kramer*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

Neurofibromatosis has been known to involve blood vessels throughout the body. Pulmonary involvement with interstitial fibrosing alveolitis has been described but no case of pulmonary vascular involvement has been reported to date. A 51 year old patient with cutaneous neurofibromatosis is described who presented with severe pulmonary hypertension and radiographic, scintigraphic, and angiographic evidence of chronic thromboembolic pulmonary hypertension. Severe intimal fibrosis consistent with vascular involvement with neurofibromatosis was found on endarterectomy with no evidence of pulmonary thromboembolism. Neurofibromatosis of pulmonary arteries should be considered as a possible cause of pulmonary hypertension.

Original languageEnglish
Pages (from-to)858-859
Number of pages2
JournalThorax
Volume54
Issue number9
DOIs
StatePublished - 1999
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Intimal fibrosis
  • Neurofibromatosis
  • Pulmonary thromboembolism

Fingerprint

Dive into the research topics of 'Pulmonary hypertension secondary to neurofibromatosis: Intimal fibrosis versus thromboembolism'. Together they form a unique fingerprint.

Cite this